Your browser doesn't support javascript.
loading
Predictors of bowel damage in the long-term progression of Crohn's disease.
Fernández-Clotet, Agnes; Panés, Julian; Ricart, Elena; Castro-Poceiro, Jesús; Masamunt, Maria Carme; Rodríguez, Sonia; Caballol, Berta; Ordás, Ingrid; Rimola, Jordi.
Afiliação
  • Fernández-Clotet A; Department of Gastroenterology, Hospital Clinic, Barcelona 08036, Spain.
  • Panés J; Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain.
  • Ricart E; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, CIBEREHD, Madrid 28029, Spain.
  • Castro-Poceiro J; Department of Gastroenterology, Hospital Clinic, Barcelona 08036, Spain.
  • Masamunt MC; Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain.
  • Rodríguez S; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, CIBEREHD, Madrid 28029, Spain.
  • Caballol B; Department of Gastroenterology, Hospital Clinic, Barcelona 08036, Spain.
  • Ordás I; Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain.
  • Rimola J; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, CIBEREHD, Madrid 28029, Spain.
World J Clin Cases ; 10(33): 12208-12220, 2022 Nov 26.
Article em En | MEDLINE | ID: mdl-36483818
ABSTRACT

BACKGROUND:

Crohn's disease (CD) is a chronic inflammatory bowel disorder that progresses to bowel damage (BD) over time. An image-based index, the Lémann index (LI), has been developed to measure cumulative BD.

AIM:

To characterize the long-term progression of BD in CD based on changes in the LI and to determine risk factors for long-term progression.

METHODS:

This was a single-center longitudinal cohort study. Patients who had participated in prospective studies on the accuracy of magnetic resonance imaging using endoscopy as a gold standard and who had a follow-up of at least 5 years were re-evaluated after 5-12 years.

RESULTS:

Seventy-two patients were included. LI increased in 38 patients (52.8%), remained unchanged in 9 patients (12.5%), and decreased in 25 patients (34.7%). The small bowel score and surgery subscale significantly increased (P = 0.002 and P = 0.001, respectively), whereas the fistulizing subscale significantly decreased (P = 0.001). Baseline parameters associated with BD progression were ileal location (P = 0.026), CD phenotype [stricturing, fistulizing, or both (P = 0.007, P = 0.006, and P = 0.035, respectively)], disease duration > 10 years (P = 0.019), and baseline LI stricturing score (P = 0.049). No correlation was observed between BD progression and baseline clinical activity, biological markers, or severity of endoscopic lesions.

CONCLUSION:

BD, as assessed by the LI, progressed in half of the patients with CD over a period of 5-12 years. The main determinants of BD progression were ileal location, stricturing/fistulizing phenotype, and disease duration.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article